Effects of adjuvant chemotherapy on the natural history and likelihood of therapeutic efficacy in advanced breast cancer patients: a critical literature review.

This publication has 55 references indexed in Scilit:

• Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.
  Journal of Clinical Oncology, 1998
• Do authors of review articles use systematic methods to identify, assess and synthesize information?
  Annals of Oncology, 1997
• Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.
  Journal of Clinical Oncology, 1997
• Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer.
  Journal of Clinical Oncology, 1997
• Recent Trends in U.S. Breast Cancer Incidence, Survival, and Mortality Rates
  JNCI Journal of the National Cancer Institute, 1996
• Review of survival analyses published in cancer journals
  British Journal of Cancer, 1995
• Statistical aspects of prognostic factor studies in oncology
  British Journal of Cancer, 1994
• Effect of adjuvant systemic therapy on response to treatment after relapse
  Cancer Treatment Reviews, 1993
• Systemic Therapy of Advanced Breast Cancer
  Drugs, 1992
• Reporting results of cancer treatment
  Cancer, 1981